- in 1999.
Hyftor (
sirolimus gel) was
approved for
topical treatment of
facial angiofibroma in the
European Union in May 2023.
Sirolimus is
indicated for...
- needed] It is the 40-O-(2-hydroxyethyl)
derivative of
sirolimus and
works similarly to
sirolimus as an
inhibitor of
mammalian target of
rapamycin (mTOR)...
-
Everolimus is an
analog of
sirolimus and also is an mTOR inhibitor.
Zotarolimus is a semi-synthetic
derivative of
sirolimus used in drug-eluting stents...
-
lymphatics feeding into the lymphocele."
Sirolimus is used to
treat lymphangioma.
Treatment with
sirolimus can
decrease pain and the
fullness of venous...
-
sites for mTOR and FKBP12. The
bacterial natural product rapamycin or
sirolimus, a
cytostatic agent, has been used in
combination therapy with corticosteroids...
-
medications (dapsone, sulfasalazine),
immunosuppressants (cyclosporin,
sirolimus) or
other medications like
omalizumab can be used.
These options are explained...
-
Sirolimus, a
compound that
inhibits mTOR signalling, is
being studied to
treat plexiform neurofibromas. The
combination of
erlotinib with
sirolimus was...
- (mTORC1) led to
successful use of
rapamycin analog sirolimus in
clinical trials and FDA
approval of
sirolimus for
treatment of LAM. TSC1 and TSC2 form a tumor...
-
triiodothyronine Rifampicin Rifaximin Rimexolone Riodipine Ritonavir Simvastatin Sirolimus Spironolactone Spiroxatrine SR-12813
Suberoylanilide Sulfisoxazole Suramin...
- hypomagnesemia, hyperglycemia,
diabetes mellitus, itching, lung
damage (
sirolimus also
causes lung damage), and
various neuropsychiatric problems such as...
